SEC Form 4 · accession 0001235802-16-000243
COGENTIX MEDICAL INC /DE/ · CGNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Kill
Officer — Chairman, President and CEO · Director
Period of report
Apr 21, 2016
Accepted (ET)
Jun 7, 2016 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000894237
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 21, 2016 | F | 12,233 | $1.07 | D | 289,493 | D | |
| Common StockF1 | Apr 27, 2016 | F | 24,401 | $1.02 | D | 265,092 | D | |
| Common Stock | holding | — | — | — | 279,748 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 167,240 shares that will be issued over time upon vesting pursuant to restricted stock grants.